Anuh Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Anuh Pharma Ltd. on BSE

Search Inside the pdf :

Anuh Pharma Ltd.

08 Apr 2025

174.50

1.54%

Company Update

Anuh Pharma Ltd - 506260 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2025 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) of our company. We request you to kindly take the same on record.

pdf

Anuh Pharma Ltd.

26 Mar 2025

174.50

1.54%

SAST

Anuh Pharma Ltd - 506260 - Closure of Trading Window

BSE India

Intimation regarding the Closure of Trading Window for dealing in securities of the company shall remain closed from Tuesday, 01st April, 2025 till the expiry of 48 hours after the declaration of Audited Financial Results for the year ended 31st March, 2025.

pdf

Anuh Pharma Ltd.

13 Feb 2025, 04:47PM

174.50

1.54%

Company Update

ANUH PHARMA LTD. - 506260 - Non-Applicability Of Statement Of Deviation(S) And Variation(S) Under Regulation 32(1), …

BSE India

Non-applicability of Statement of Deviation(s) and Variation(s) under Regulation 32(1), of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Anuh Pharma Ltd.

11 Feb 2025

174.50

1.54%

Company Update

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

In furtherance to our Disclosure under Regulation 30 for Newspaper Publication for Unaudited Financial Results for the quarter ended 31st December, 2024 being published on 09th February, 2025, please find enclosed herewith the newspaper cutting for the corrigendum published in Mumbai Lakshdeep (Marathi Language) on 11th February, 2025

pdf

Anuh Pharma Ltd.

09 Feb 2025

174.50

1.54%

Company Update

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of the Un-audited financial results for the quarter ended 31st December, 2024, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi language on 09th February, 2025.

pdf

Anuh Pharma Ltd.

07 Feb 2025

174.50

1.54%

Corp. Note

ANUH PHARMA LTD. - 506260 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the Quarter ended 31st December, 2024

pdf

Anuh Pharma Ltd.

07 Feb 2025

174.50

1.54%

Result

ANUH PHARMA LTD. - 506260 - Results - Financial Results For December 31, 2024 (Quarter Ended …

BSE India

Un-Audited Financial Results for the Quarter ended 31st December, 2024

pdf

Anuh Pharma Ltd.

07 Feb 2025

174.50

1.54%

Board Meeting

ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Board Meeting Outcome For Meeting Held …

BSE India

To consider and approve the Un-audited Financial Results and Limited Review Report for the Quarter ended 31st December, 2024.

pdf

Anuh Pharma Ltd.

31 Jan 2025

174.50

1.54%

Board Meeting

ANUH PHARMA LTD. - 506260 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial …

BSE India

ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 ,inter alia, to consider and approve unaudited financial results for the quarter ended 31st December, 2024 and to consider any other matter with the permission of the Chairman.

pdf

Anuh Pharma Ltd.

13 Jan 2025, 05:15PM

174.50

1.54%

Company Update

ANUH PHARMA LTD. - 506260 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2024 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) of our company. We request you to kindly take the same on record.

pdf

Is Anuh Pharma Ltd. worth buying?

225 Votes:

Buy 72.89%

Sell 10.67%

Hold 16.44%